Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
Norrby
S R
SR
Department of Infectious Diseases, University of Lund, Lund University Hospital, Sweden.
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001424:Bacterial Infections; D004352:Drug Resistance, Microbial; D024841:Fluoroquinolones; D006801:Humans; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D015363:Quinolones / Q000008:administration & dosage / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D010879:Piperazines; D015363:Quinolones; C075375:grepafloxacin